Carboxypeptidase inhibition by NvCI suppresses airway hyperreactivity in a mouse asthma model

Allergy. 2021 Jul;76(7):2234-2237. doi: 10.1111/all.14730. Epub 2021 Jan 19.

Authors

Ida Waern¹, Sowsan Taha¹, Julia Lorenzo², David Montpeyó², Giovanni Covaleda-Cortés², Francesc Xavier Avilés², Sara Wernersson¹

Affiliations

¹ Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Sweden.
² Institut de Biotecnologia i de Biomedicina (IBB) and Departament de Bioquímica i de Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain.

PMID: 33387397
DOI: 10.1111/all.14730

No abstract available

Keywords: NvCI carboxypeptidase inhibitor; asthma; carboxypeptidase activity; house dust mite; mast cell.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Allergens
Animals
Asthma* / drug therapy
Bronchial Hyperreactivity*
Carboxypeptidases
Disease Models, Animal
Mice
Pyroglyphidae

Substances

Allergens
Carboxypeptidases